Immediate Impact
25 standout
Citing Papers
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Long COVID: a clinical update
2024 Standout
Works of Constant Josse being referenced
Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC).
2023
Malnutrition: Percentage and Association with Prognosis in Patients Hospitalized for Coronavirus Disease 2019
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Constant Josse | 106 | 30 | 29 | 57 | 55 | 13 | 227 | |
| Andrew J. Vincz | 32 | 17 | 42 | 42 | 33 | 12 | 296 | |
| Sena Kuyumcu | 36 | 46 | 159 | 36 | 38 | 9 | 297 | |
| Paul Strock | 84 | 23 | 12 | 36 | 10 | 13 | 233 | |
| Benjamin Assouline | 67 | 12 | 41 | 31 | 41 | 17 | 216 | |
| H. L. Price | 87 | 9 | 4 | 32 | 28 | 15 | 284 | |
| Abdul Jabbar Omar Alsaleh | 116 | 12 | 8 | 77 | 75 | 10 | 290 | |
| Adam Mikstacki | 50 | 34 | 52 | 14 | 93 | 20 | 295 | |
| Pui San Loh | 64 | 7 | 7 | 24 | 83 | 19 | 179 | |
| Jean-Paul Dutertre | 40 | 28 | 11 | 23 | 27 | 15 | 297 | |
| Riccardo Giudici | 58 | 21 | 20 | 28 | 16 | 16 | 245 |
All Works
Login with ORCID to disown or claim papers
Loading papers...